Shilpa Biologicals appoints Dr. Sridevi Khambhampaty as CEO
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
This approval is backed by a decade of proven safety and efficacy data of Ocrevus® IV, with over 350,000 people treated globally
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
Sanofi would not manufacture or market any product which infringes the amended claims of Panacea patent, IN272351
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment options while showing safety and efficacy consistent with intravenous
Total investment incurred for setting up the new R&D Rs 250 crore
Subscribe To Our Newsletter & Stay Updated